FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump blames ‘VANDALS’ for damaging National Mall grass after World War II Memorial graffiti

Tupac Shakur murder trial kicks off as Duane ‘Keffe D’ Davis faces jury nearly three decades after shooting

Texas Man Kills Alleged Intruder in Shootout – Police Say Suspect Had a Protective Order Filed Against Him

Cops Address Foul Play Questions After Actress Hayden Panettiere Found Dead at Age 36

US awards Raytheon $22.9B Tomahawk deal as Trump dismisses weapons stockpile concerns

Actress Hayden Panettiere dies suddenly at age 36 and more top headlines

CEO says doing business in state ‘sucks’ as company heads to Texas amid California exodus

Far-left politicians still using ActBlue as 88-year-old disputes donating nearly $150,000 to fundraising giant

As Pelosi’s exit nears, San Francisco Democratic candidates fight over what comes next

Russell Fry endorses ex-rival Darline Graham after failing to advance to special GOP US Senate primary runoff

Homeland Security investigated Minnesota labor unions as part of ‘terrorist financing’ probe in anti-ICE antifa case: Court documents

Trump blames vandals for dead grass on National Mall where he hosted 4th of July celebration

NYPD officers fatally shoot man armed with butcher knife after he advanced toward cops: police

Louisiana man accused of killing wife, propping her body up for multistate drive

Todd Blanche backs Jeanine Pirro after Lincoln Memorial pool vandalism case dismissal

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”